These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20957343)

  • 1. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.
    Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T
    Diabetologia; 2011 Jan; 54(1):103-10. PubMed ID: 20957343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
    Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; Hansen T; Madsbad S; Holst JJ; Vølund A; Poulsen P; Groop L; Pedersen O; Vaag AA
    Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.
    Færch K; Pilgaard K; Knop FK; Hansen T; Pedersen O; Jørgensen T; Holst JJ
    Diabetes Obes Metab; 2013 Jan; 15(1):91-5. PubMed ID: 22862926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
    Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
    Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant.
    Daniele G; Gaggini M; Comassi M; Bianchi C; Basta G; Dardano A; Miccoli R; Mari A; Gastaldelli A; Del Prato S
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1160-7. PubMed ID: 26046964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between TCF7L2 gene polymorphism and genetic susceptibility in women with gestational diabetes mellitus].
    Shi X; Cai Q; Zou M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):588-93. PubMed ID: 25354859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes.
    Ferreira MC; da Silva MER; Fukui RT; do Carmo Arruda-Marques M; Azhar S; Dos Santos RF
    Diabetol Metab Syndr; 2019; 11():10. PubMed ID: 30700996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
    Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
    Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ferreira MC; da Silva MER; Fukui RT; Arruda-Marques MDC; Dos Santos RF
    Diabetol Metab Syndr; 2018; 10():37. PubMed ID: 29736187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
    Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B
    Diabetes; 2004 Mar; 53(3):654-62. PubMed ID: 14988249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon-like peptide 1.
    Silbernagel G; Renner W; Grammer TB; Hügl SR; Bertram J; Kleber ME; Hoffmann MM; Winkelmann BR; März W; Boehm BO
    Diabetes Metab Res Rev; 2011 Jul; 27(5):499-505. PubMed ID: 21384500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals.
    Gasbjerg LS; Helsted MM; Hartmann B; Sparre-Ulrich AH; Veedfald S; Stensen S; Lanng AR; Bergmann NC; Christensen MB; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32077470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group.
    Shokouhi S; Delpisheh A; Haghani K; Mahdizadeh M; Bakhtiyari S
    Clin Lab; 2014; 60(8):1269-76. PubMed ID: 25185411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.
    da Silva Xavier G; Mondragon A; Sun G; Chen L; McGinty JA; French PM; Rutter GA
    Diabetologia; 2012 Oct; 55(10):2667-2676. PubMed ID: 22717537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
    Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose tolerance and free fatty acid metabolism in adults with variations in TCF7L2 rs7903146.
    Lu J; Varghese RT; Zhou L; Vella A; Jensen MD
    Metabolism; 2017 Mar; 68():55-63. PubMed ID: 28183453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the rs7903146 Polymorphism in the TCF7L2 Gene and Parameters Derived with Continuous Glucose Monitoring in Individuals without Diabetes.
    van der Kroef S; Noordam R; Deelen J; Akintola AA; Jansen SW; Postmus I; Wijsman CA; Beekman M; Mooijaart SP; Slagboom PE; van Heemst D
    PLoS One; 2016; 11(2):e0149992. PubMed ID: 26914832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.